Artificial Intelligence & Machine Learning

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

Established in 1996, VantagePoint Capital Partners is a global venture investor with a focus on energy innovation and efficiency. With over $4 billion under management, the firm supports companies from start-up to scale-up, providing not only capital but also strategic resources, partnership alliances, and ongoing support. Headquartered in Silicon Valley, VantagePoint has offices in Beijing and strategic partners worldwide, emphasizing its commitment to energy innovation and efficiency.

Pittsburgh Life Sciences Greenhouse (PLSG) is a leading life sciences investment firm in Western Pennsylvania, dedicated to fostering innovation and commercialization in the life sciences sector. PLSG supports entrepreneurs and emerging companies by providing funding, strategic guidance, and access to resources, with a focus on improving healthcare outcomes and driving economic growth in the region. The firm is deeply connected to the growing impact of data analytics in healthcare and is committed to supporting underserved groups through initiatives like the 'Under 40, Underserved Advisory Board'.

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

IU Ventures is a 501(c)(3) affiliate of Indiana University focused on advancing high potential new venture opportunities. It supports IU students, faculty, staff, and alumni in creating and growing startups that generate significant social and economic impact for Indiana University, the state of Indiana, and the world. The organization manages several investment programs, including the IU Philanthropic Venture Fund, IU Angel Network, and IU Founders & Funders Network, to foster a pervasive entrepreneurial culture and contribute to economic development.

Brain Trust Accelerator Fund is a venture capital firm focused on impact investing in brain-related diseases. The firm specializes in translational stage investments that address the diagnosis and treatment of these diseases. With a strong track record, Fund I has generated top-tier returns, benefiting up to ten million patients and delivering significant charitable contributions. The firm leverages scientific advancements and market opportunities to invest in early-stage, translational research, aiming to transform pioneering research into meaningful clinical benefits.

Research Corporation Technologies (RCT) is a technology investment and management company based in Tucson, Arizona. Founded in 1987, RCT provides early-stage funding and development for promising biomedical companies and technologies, focusing on innovations originating from universities and research institutions worldwide. With assets exceeding $500 million, RCT advances technology development through venture investments, partnerships, and special licensing programs, supporting the commercialization of academic innovations.

Camino Real Capital Partners, LLC (CRCP) is a private investment firm based in Santa Fe, New Mexico, dedicated to investing in America's leading innovators and emerging technologies. The firm emphasizes building relationships, fostering growth opportunities, and creating value. CRCP focuses on transformative technology, emerging medical devices, life science innovations, and cutting-edge service providers in the energy sector. The firm invests its own capital alongside a network of accredited co-venturers, providing technology and marketing insights and management guidance to early-stage innovators.

Glynn Capital is a private and public technology investment firm focused on long-term investments in technology growth companies. The firm aims to partner with exceptional teams leveraging disruptive technologies to address markets ripe for change. Glynn Capital invests in both private early-growth stage companies and public durable growth companies, seeking to add value through experience and networks.

Triangle Angel Partners (TAP) is an angel fund based in the Research Triangle Park area of North Carolina. Formed in 2011, TAP aims to leverage the expertise and capital of its members to support local entrepreneurs in high-tech start-ups. TAP provides not only financial investment but also mentoring, counseling, and access to a vast network of potential investors, customers, and strategic partners. The firm has launched two funds, TAP I and TAP II, with a focus on investing in companies within a half-day's drive of Research Triangle Park.

NSG Ventures is a global biotech venture capital firm managed by founders and scientists. The firm is dedicated to investing in innovative solutions to tackle humanity's greatest challenges, particularly diseases. NSG Ventures partners with exceptional teams to push scientific boundaries and achieve medical breakthroughs.

Black Diamond Ventures (BDV) is a transformational venture capital firm with over two decades of experience in hybrid investing. Founded by Chris Lucas, BDV focuses on multi-stage investments in biotech, deep tech, and med tech sectors, supporting visionary founders with strategic and operational guidance. The firm is committed to building relationships among investors and their investments, helping founders reach the next level through a network of partners and strategic opportunities.

MVM Partners LLP is a venture capital firm that has been investing in high-growth healthcare businesses since 1997. With a global presence in Boston, London, and the San Francisco Bay Area, MVM focuses on a broad range of healthcare sectors including medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, and digital health. The firm collaborates with top management teams to bring innovative products to market, drive growth, and establish new standards of care in medicine.

Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.